Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New molecular targets in the treatment of NSCLC.
Schettino C, Bareschino MA, Sacco PC, Maione P, Rossi A, Casaluce F, Sgambato A, Gridelli C. Schettino C, et al. Among authors: casaluce f. Curr Pharm Des. 2013;19(30):5333-43. doi: 10.2174/13816128113199990343. Curr Pharm Des. 2013. PMID: 23394083 Review.
Emerging mitotic inhibitors for non-small cell carcinoma.
Casaluce F, Sgambato A, Maione P, Ciardiello F, Gridelli C. Casaluce F, et al. Expert Opin Emerg Drugs. 2013 Mar;18(1):97-107. doi: 10.1517/14728214.2013.777426. Expert Opin Emerg Drugs. 2013. PMID: 23448156 Review.
Medical treatment of small cell lung cancer: state of the art and new development.
Sgambato A, Casaluce F, Maione P, Rossi A, Sacco PC, Panzone F, Ciardiello F, Gridelli C. Sgambato A, et al. Among authors: casaluce f. Expert Opin Pharmacother. 2013 Oct;14(15):2019-31. doi: 10.1517/14656566.2013.823401. Epub 2013 Aug 1. Expert Opin Pharmacother. 2013. PMID: 23901936 Review.
ALK inhibitors in the treatment of advanced NSCLC.
Gridelli C, Peters S, Sgambato A, Casaluce F, Adjei AA, Ciardiello F. Gridelli C, et al. Among authors: casaluce f. Cancer Treat Rev. 2014 Mar;40(2):300-6. doi: 10.1016/j.ctrv.2013.07.002. Epub 2013 Aug 7. Cancer Treat Rev. 2014. PMID: 23931927 Review.
Irreversible EGFR inhibitors in the treatment of advanced NSCLC.
Maione P, Rossi A, Bareschino M, Sacco PC, Schettino C, Casaluce F, Sgambato A, Gridelli C. Maione P, et al. Among authors: casaluce f. Curr Pharm Des. 2014;20(24):3894-900. doi: 10.2174/13816128113196660764. Curr Pharm Des. 2014. PMID: 24138713 Review.
The PI3k inhibitors: new hopes in the battle against advanced NSCLC.
Sacco PC, Maione P, Rossi A, Barecshino MA, Sgambato A, Casaluce F, Napolitano A, Palazzolo G, Rossi E, Ferrara C, Gridelli C. Sacco PC, et al. Among authors: casaluce f. Front Biosci (Landmark Ed). 2014 Jan 1;19(2):259-71. doi: 10.2741/4205. Front Biosci (Landmark Ed). 2014. PMID: 24389182 Free article. Review.
42 results